Thrombolytic therapy vs. anticoagulation for PE.
Mofredj
Ali
A
Baraka
Daoud
D
Beldjoudi
Brahim
B
D000925:Anticoagulants / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006439:Hemodynamics; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000401:mortality
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin